Hanmi Pharm. Co., Ltd. (KRX:128940)
South Korea · Delayed Price · Currency is KRW 503,000
-12,000 (-2.33%)
Sep 18, 2026, 3:30 PM KST
Hanmi Pharm. Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, Hanmi Pharm. stock has a consensus rating of "Buy" and an average price target of ₩650,833. The average 1-year stock price forecast is 29.39% higher than the current stock price, while the lowest is ₩550,000 (+9.34%) and the highest is ₩760,000 (+51.09%).
Price Target: ₩650,833 (+29.39%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Hanmi Pharm. stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 6 | 5 | 6 | 6 | 6 |
| Buy | 8 | 8 | 7 | 6 | 5 | 5 |
| Hold | 0 | 1 | 1 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 15 | 13 | 12 | 12 | 12 |
Financial Forecast
Revenue This Year
1.59T
from 1.55T
Increased by 2.65%
Revenue Next Year
1.77T
from 1.59T
Increased by 11.38%
EPS This Year
16.65K
from 13.36K
Increased by 24.59%
EPS Next Year
17.87K
from 16.65K
Increased by 7.36%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is KRW.